Pharmacokinetics, Safety, and Immunogenicity of Intravenous and Subcutaneous Single-Dose QX002N Injection in Healthy Subjects: A Randomized, Open, Parallel, Single-Center, Phase I Study

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Rheumatology and Therapy

Topics

Medicine

Immunology

Internal Medicine

Surgery

Genetics

Show all topics

DOI

10.1007/s40744-024-00683-0

License

CC-BY-NC

Other Formats

PDF